Literature DB >> 24050627

Pathogenesis of idiopathic pulmonary fibrosis.

Paul J Wolters1, Harold R Collard, Kirk D Jones.   

Abstract

Idiopathic pulmonary fibrosis (IPF) is a fibrosing interstitial lung disease associated with aging that is characterized by the histopathological pattern of usual interstitial pneumonia. Although an understanding of the pathogenesis of IPF is incomplete, recent advances delineating specific clinical and pathologic features of IPF have led to better definition of the molecular pathways that are pathologically activated in the disease. In this review we highlight several of these advances, with a focus on genetic predisposition to IPF and how genetic changes, which occur primarily in epithelial cells, lead to activation of profibrotic pathways in epithelial cells. We then discuss the pathologic changes within IPF fibroblasts and the extracellular matrix, and we conclude with a summary of how these profibrotic pathways may be interrelated.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24050627      PMCID: PMC4116429          DOI: 10.1146/annurev-pathol-012513-104706

Source DB:  PubMed          Journal:  Annu Rev Pathol        ISSN: 1553-4006            Impact factor:   23.472


  139 in total

1.  Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease.

Authors:  Borna Mehrad; Marie D Burdick; David A Zisman; Michael P Keane; John A Belperio; Robert M Strieter
Journal:  Biochem Biophys Res Commun       Date:  2006-12-11       Impact factor: 3.575

2.  Incidence and prevalence of idiopathic pulmonary fibrosis.

Authors:  Ganesh Raghu; Derek Weycker; John Edelsberg; Williamson Z Bradford; Gerry Oster
Journal:  Am J Respir Crit Care Med       Date:  2006-06-29       Impact factor: 21.405

3.  Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis.

Authors:  Marco Chilosi; Venerino Poletti; Alberto Zamò; Maurizio Lestani; Licia Montagna; Paola Piccoli; Serena Pedron; Manuela Bertaso; Aldo Scarpa; Bruno Murer; Alessandra Cancellieri; Roberta Maestro; Gianpietro Semenzato; Claudio Doglioni
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

4.  Role of endoplasmic reticulum stress in epithelial-mesenchymal transition of alveolar epithelial cells: effects of misfolded surfactant protein.

Authors:  Qian Zhong; Beiyun Zhou; David K Ann; Parviz Minoo; Yixin Liu; Agnes Banfalvi; Manda S Krishnaveni; Mickael Dubourd; Lucas Demaio; Brigham C Willis; Kwang-Jin Kim; Roland M duBois; Edward D Crandall; Michael F Beers; Zea Borok
Journal:  Am J Respir Cell Mol Biol       Date:  2010-12-17       Impact factor: 6.914

5.  Surfactant protein A2 mutations associated with pulmonary fibrosis lead to protein instability and endoplasmic reticulum stress.

Authors:  Meenakshi Maitra; Yongyu Wang; Robert D Gerard; Carole R Mendelson; Christine Kim Garcia
Journal:  J Biol Chem       Date:  2010-05-13       Impact factor: 5.157

6.  Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury.

Authors:  R Gisli Jenkins; Xiao Su; George Su; Christopher J Scotton; Eric Camerer; Geoffrey J Laurent; George E Davis; Rachel C Chambers; Michael A Matthay; Dean Sheppard
Journal:  J Clin Invest       Date:  2006-05-18       Impact factor: 14.808

7.  Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis.

Authors:  K E Greene; T E King; Y Kuroki; B Bucher-Bartelson; G W Hunninghake; L S Newman; H Nagae; R J Mason
Journal:  Eur Respir J       Date:  2002-03       Impact factor: 16.671

8.  Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis.

Authors:  R W Tobin; C E Pope; C A Pellegrini; M J Emond; J Sillery; G Raghu
Journal:  Am J Respir Crit Care Med       Date:  1998-12       Impact factor: 21.405

9.  Pulmonary epithelium is a prominent source of proteinase-activated receptor-1-inducible CCL2 in pulmonary fibrosis.

Authors:  Paul F Mercer; Robin H Johns; Chris J Scotton; Malvina A Krupiczojc; Melanie Königshoff; David C J Howell; Robin J McAnulty; Anuk Das; Andrew J Thorley; Terry D Tetley; Oliver Eickelberg; Rachel C Chambers
Journal:  Am J Respir Crit Care Med       Date:  2008-12-05       Impact factor: 21.405

10.  Cleaved cytokeratin-18 is a mechanistically informative biomarker in idiopathic pulmonary fibrosis.

Authors:  Seung-Ick Cha; Christopher J Ryerson; Joyce S Lee; Jasleen Kukreja; Sophia S Barry; Kirk D Jones; Brett M Elicker; Dong Soon Kim; Feroz R Papa; Harold R Collard; Paul J Wolters
Journal:  Respir Res       Date:  2012-11-20
View more
  252 in total

1.  Attenuated pulmonary fibrosis in sialidase-3 knockout (Neu3-/-) mice.

Authors:  Tejas R Karhadkar; Wensheng Chen; Richard H Gomer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-10-16       Impact factor: 5.464

2.  Heterogeneity of Fibroblasts and Myofibroblasts in Pulmonary Fibrosis.

Authors:  David M Habiel; Cory M Hogaboam
Journal:  Curr Pathobiol Rep       Date:  2017-05-02

3.  Targeting of Discoidin Domain Receptor 2 (DDR2) Prevents Myofibroblast Activation and Neovessel Formation During Pulmonary Fibrosis.

Authors:  Hu Zhao; Huan Bian; Xin Bu; Shuya Zhang; Pan Zhang; Jiangtian Yu; Xiaofeng Lai; Di Li; Chuchao Zhu; Libo Yao; Jin Su
Journal:  Mol Ther       Date:  2016-05-27       Impact factor: 11.454

4.  miR-34a Inhibits Lung Fibrosis by Inducing Lung Fibroblast Senescence.

Authors:  Huachun Cui; Jing Ge; Na Xie; Sami Banerjee; Yong Zhou; Veena B Antony; Victor J Thannickal; Gang Liu
Journal:  Am J Respir Cell Mol Biol       Date:  2017-02       Impact factor: 6.914

5.  MicroRNA-101 attenuates pulmonary fibrosis by inhibiting fibroblast proliferation and activation.

Authors:  Chaoqun Huang; Xiao Xiao; Ye Yang; Amorite Mishra; Yurong Liang; Xiangming Zeng; Xiaoyun Yang; Dao Xu; Michael R Blackburn; Craig A Henke; Lin Liu
Journal:  J Biol Chem       Date:  2017-07-18       Impact factor: 5.157

6.  Telomere dysfunction in alveolar epithelial cells causes lung remodeling and fibrosis.

Authors:  Ram P Naikawadi; Supparerk Disayabutr; Benat Mallavia; Matthew L Donne; Gary Green; Janet L La; Jason R Rock; Mark R Looney; Paul J Wolters
Journal:  JCI Insight       Date:  2016-09-08

Review 7.  Autophagy in Pulmonary Diseases.

Authors:  Kiichi Nakahira; Maria Angelica Pabon Porras; Augustine M K Choi
Journal:  Am J Respir Crit Care Med       Date:  2016-11-15       Impact factor: 21.405

Review 8.  Cellular Metabolism in Lung Health and Disease.

Authors:  Gang Liu; Ross Summer
Journal:  Annu Rev Physiol       Date:  2018-11-28       Impact factor: 19.318

9.  Epidemiology of idiopathic pulmonary fibrosis: a population-based study in primary care.

Authors:  Sergio Harari; Michele Davì; Alice Biffi; Antonella Caminati; Alessandra Ghirardini; Valeria Lovato; Claudio Cricelli; Francesco Lapi
Journal:  Intern Emerg Med       Date:  2019-09-20       Impact factor: 3.397

10.  Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis.

Authors:  Yan Xu; Takako Mizuno; Anusha Sridharan; Yina Du; Minzhe Guo; Jie Tang; Kathryn A Wikenheiser-Brokamp; Anne-Karina T Perl; Vincent A Funari; Jason J Gokey; Barry R Stripp; Jeffrey A Whitsett
Journal:  JCI Insight       Date:  2016-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.